An association between anti-platelet drug use and reduced cancer prevalence in diabetic patients: results from the Vermont Diabetes Information System Study

BACKGROUND: Diabetes is associated with an increased risk of several malignancies. Both diabetic patients and patients with cancer have an increase in platelet reactivity and platelet activation has recently emerged as a potential mediator of cancer progression. Drug therapies, such as aspirin, that...

Descripción completa

Detalles Bibliográficos
Autores principales: Holmes, Chris E, Ramos-Nino, Maria E, Littenberg, Benjamin
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2893115/
https://www.ncbi.nlm.nih.gov/pubmed/20546622
http://dx.doi.org/10.1186/1471-2407-10-289

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2893115/
https://www.ncbi.nlm.nih.gov/pubmed/20546622
http://dx.doi.org/10.1186/1471-2407-10-289

Ejemplares similares